ClinicalTrials.Veeva

Menu

Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients

R

RS Medical

Status and phase

Terminated
Phase 4

Conditions

Low Back Pain

Treatments

Device: Vertis Percutaneous Neuromodulation Therapy (PNT)
Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00290238
RSMED-K011702-PNT02

Details and patient eligibility

About

The purpose of this study is to assess the benefits of Percutaneous Neuromodulation Therapy when compared to a reference sham treatment in the treatment of patients who have undergone surgical intervention for chronic low back pain with or without a radiating lower extremity pain component.

Enrollment

122 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Low back pain for at least 6 months
  • If lower extremity pain present, must be present for at least 3 months
  • Visual analog scale (VAS) score for low back pain at least 50 out of 100
  • Lumbar or lumbosacral surgical intervention without pain relief
  • Central sensitization symptoms
  • Agrees to follow randomized treatment plan
  • 18 years of age or older
  • Signed informed consent form

Exclusion criteria

  • Significant change to low back or lower extremity pain within 4 weeks prior to enrollment
  • Nociceptive and/or neuropathic pain symptoms in the spine due to structural and/or mechanical instabilities
  • Three or more lumbar or lumbosacral surgical interventions; one or more surgical interventions in areas other than lumbar or lumbosacral spine
  • Three or more lumbar vertebral segments fused
  • Lumbar or lumbosacral surgical intervention in last 9 months; areas other than lumbar or lumbosacral in last 12 months
  • Any additional surgical intervention required 3 months post-enrollment
  • Symptoms consistent with sympathetically-maintained pain
  • Evidence of serious neurological deficits or impairments
  • Significant changes in pain medications within 4 weeks prior to enrollment
  • Psychosocial issues that conflict with valid reporting by patient
  • Prior treatment with percutaneous electrical stimulation or sensitivity to electrical stimulation
  • Current use of another electrical stimulation device for low back or lower extremity pain
  • Current enrollment in another clinical trial within the last 30 days
  • Current or prior malignancy or cancer
  • Serious or uncontrolled systemic illness
  • Body mass index (BMI) greater than 40
  • Pregnant or intends to become pregnant during the study
  • Implanted medical device
  • Relationship with study staff
  • Unable to attend study office visits or complete study measures

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

122 participants in 2 patient groups

PNT
Experimental group
Treatment:
Device: Vertis Percutaneous Neuromodulation Therapy (PNT)
TENS
Sham Comparator group
Treatment:
Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems